BioCentury
ARTICLE | Company News

Bavarian Nordic, U.S. Department of Health and Human Services infectious news

November 25, 2013 8:00 AM UTC

Bavarian Nordic delivered 20 million doses of Imvamune smallpox vaccine to the U.S. Strategic National Stockpile under a 2007 contract valued at $549 million with HHS's Biomedical Advanced Research and Development Authority (BARDA). In April, BARDA awarded the company an additional contract valued at up to $228 million to supply 8 million doses of Imvamune needed to maintain the 20 million dose stockpile over time (see BioCentury, April 22). ...